<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Omega</journal-id><journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id><journal-id journal-id-type="publisher-id">ao</journal-id><journal-id journal-id-type="coden">acsodf</journal-id><journal-title-group><journal-title>ACS Omega</journal-title></journal-title-group><issn pub-type="epub">2470-1343</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6647956</article-id><article-id pub-id-type="doi">10.1021/acsomega.9b00699</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Quinazolinone Synthesis through Base-Promoted S<sub>N</sub>Ar Reaction
of <italic>ortho</italic>-Fluorobenzamides with
Amides Followed by Cyclization</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Iqbal</surname><given-names>Muhammad
Asif</given-names></name></contrib><contrib contrib-type="author" id="ath2"><name><surname>Lu</surname><given-names>Le</given-names></name></contrib><contrib contrib-type="author" id="ath3"><name><surname>Mehmood</surname><given-names>Hina</given-names></name></contrib><contrib contrib-type="author" id="ath4"><name><surname>Khan</surname><given-names>Dost Muhammad</given-names></name></contrib><contrib contrib-type="author" corresp="yes" id="ath5"><name><surname>Hua</surname><given-names>Ruimao</given-names></name><xref rid="cor1" ref-type="other">*</xref></contrib><aff id="AFF-d7e78-autogenerated">Department of Chemistry, Key Laboratory
of Organic Optoelectronics &#x00026; Molecular Engineering of Ministry
of Education, <institution>Tsinghua University</institution>, Beijing 100084, <country>China</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>E-mail: <email>ruimao@mail.tsinghua.edu.cn</email>.</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>05</month><year>2019</year></pub-date><pub-date pub-type="collection"><day>31</day><month>05</month><year>2019</year></pub-date><volume>4</volume><issue>5</issue><fpage>8207</fpage><lpage>8213</lpage><history><date date-type="received"><day>13</day><month>03</month><year>2019</year></date><date date-type="accepted"><day>25</day><month>04</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 American Chemical Society</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao-2019-00699f_0008" id="ab-tgr1"/></p><p>A transition-metal-free
synthesis of quinazolin-4-ones by Cs<sub>2</sub>CO<sub>3</sub>-promoted
S<sub>N</sub>Ar reaction of <italic>ortho</italic>-fluorobenzamides
with amides followed by cyclization
in dimethyl sulfoxide has been developed. The present procedure can
provide efficient synthetic methods for the formation of both 2-substituted
and 2,3-disubstituted quinazolin-4-one rings depending on the use
of easily available starting materials and an efficient, one-pot protocol
for the synthesis of the marketed drug product of methaqualone.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ao9b00699</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ao-2019-00699f</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Quinazolin-4-ones are
an important class of heterocyclic structural
scaffolds that have been found in many natural products<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> and bioactive compounds.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> For example, the natural alkaloids of luotonin A and luotonin F
and the marketing drugs of piriqualone and methapualone are the derivatives
of quinazolin-4-one (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>). In addition, quinazolin-4-ones are also the important intermediates
for the synthesis of other nitrogen heterocyclic compounds having
physiological and biological activity.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup></p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Selected Naturally Found Alkaloids and Drugs with the Quinazolinone
Skeleton</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao-2019-00699f_0002" id="gr1" position="float"/></fig><p>Therefore, the chemistry
and the synthetic strategies for constructing
the quinazolin-4-one ring have been well investigated.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Among them, the most common and practical synthetic methods
are intermolecular annulation using <italic>ortho</italic>-aminobenzamides
or <italic>ortho</italic>-halobenzamides as starting materials.<sup><xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref></sup> For example, quinazolin-4-one derivatives can be obtained from the
cyclocondensation of <italic>ortho</italic>-aminobenzamides with aldehydes
catalyzed either by copper salts in dimethylacetamide<sup><xref ref-type="bibr" rid="cit5b">5b</xref></sup> or by bis-sulfonated ionic liquids via aerobic oxidative
reaction in water or ethanol<sup><xref ref-type="bibr" rid="cit5j">5j</xref></sup> or by aerobic
oxidative reaction in wet dimethyl sulfoxide (DMSO).<sup><xref ref-type="bibr" rid="cit5d">5d</xref></sup> The reactions of <italic>ortho</italic>-aminobenzamide
with primary alcohols in dimethyl carbonate catalyzed by iodine with
the use of DMSO as the oxidant<sup><xref ref-type="bibr" rid="cit5c">5c</xref></sup> or with
1,3-diketones in aqueous ethyl lactate catalyzed by camphorsulfonic
acid<sup><xref ref-type="bibr" rid="cit5h">5h</xref></sup> or with isocyanides and arylboronic
acids in dimethylformamide (DMF) catalyzed by PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> with the use of Cu(OAc)<sub>2</sub> as the oxidant<sup><xref ref-type="bibr" rid="cit5k">5k</xref></sup> can also afford quinazolin-4-ones. In addition,
the syntheses of quinazolin-4-ones from the intermolecular annulation
of <italic>ortho</italic>-halobenzamides are shown in <xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>. It involves the reaction
of <italic>ortho</italic>-halobenzamides with benzylamines<sup><xref ref-type="bibr" rid="cit6a">6a</xref></sup> or amino acids<sup><xref ref-type="bibr" rid="cit6b">6b</xref></sup> in
DMSO catalyzed by CuBr using air as the oxidant, the reaction of N-substituted <italic>ortho</italic>-bromobenzamides with formamide in DMF catalyzed by
CuI/4-hydroxy-<sc>l</sc>-proline,<sup><xref ref-type="bibr" rid="cit6c">6c</xref></sup><italic>ortho</italic>-bromobenzamides with aldehydes and aqueous ammonia
in DMSO catalyzed by CuBr/<sc>l</sc>-proline using Cs<sub>2</sub>CO<sub>3</sub> as the base and air as the oxidant<sup><xref ref-type="bibr" rid="cit6d">6d</xref></sup> or with the use of Cu&#x02013;Mn spinel oxide as a heterogeneous
catalyst,<sup><xref ref-type="bibr" rid="cit6f">6f</xref></sup><italic>ortho</italic>-iodobenzamides
with benzylamines or cinnamylamines in DMSO catalyzed by copper salts
with the use of K<sub>2</sub>CO<sub>3</sub> as the base and air as
the oxidant,<sup><xref ref-type="bibr" rid="cit6e">6e</xref></sup><italic>ortho</italic>-bromobenzamides
with aldehydes or alcohols, or methyl arenes catalyzed by CuI in DMSO
in the presence of the oxidant and using TMSN<sub>3</sub> as a nitrogen
source,<sup><xref ref-type="bibr" rid="cit6g">6g</xref></sup><italic>ortho</italic>-bromobenzamides
with benzylic alcohols and sodium azide catalyzed by CuO/<sc>l</sc>-proline in DMF with the use of 2,2,6,6-tetramethylpiperidine-1-oxyl
as the oxidant and TsOH&#x000b7;H<sub>2</sub>O as the additive,<sup><xref ref-type="bibr" rid="cit6h">6h</xref></sup> and <italic>ortho</italic>-halobenzamides with
nitriles catalyzed by Cu(OAc)<sub>2</sub> in the presence of <sup><italic>t</italic></sup>BuOK as the base.<sup><xref ref-type="bibr" rid="cit6i">6i</xref></sup> On the basis of the above-described procedures for the construction
of the quinazolin-4-one ring from <italic>ortho</italic>-halobenzamides
as starting materials, it is readily apparent and interesting to find
that, besides the requirement of copper catalysts, in most cases,
DMSO is used as the solvent, and inorganic bases are employed as additives.</p><fig id="sch2" position="float"><label>Scheme 2</label><caption><title>Synthesis of Quinazolin-4-ones from <italic>ortho</italic>-Halobenzamides</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao-2019-00699f_0003" id="gr2" position="float"/></fig><p>On the other hand, inorganic
base/DMSO medium have been well applied
to promote the nucleophilic haloarenes substitution of the C&#x02013;X
bond for the formation of the C&#x02013;N bond and the synthesis of
nitrogen heterocyclic compounds.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> In the
continuation of our interest in developing the efficient methods for
the synthesis of nitrogen heterocyclic compounds<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> and the application of base/DMSO-promoted S<sub>N</sub>Ar reaction for the formation of the C&#x02013;N bond,<sup><xref ref-type="bibr" rid="cit7g">7g</xref></sup> we herein would like to report a new approach
to the construction of the quinazolin-4-one ring under transition-metal-free
conditions, which involves the base-promoted S<sub>N</sub>Ar reaction
of <italic>ortho</italic>-fluorobenzamides with amides followed by
cyclization (<xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>).</p></sec><sec id="sec2"><title>Results and Discussion</title><p>Fu&#x02019;s group developed a CuBr-catalyzed
synthesis of quinazolinones
via the reaction of 2-iodo/bromobenzamides with benzylamines in DMSO
using K<sub>2</sub>CO<sub>3</sub> as the base;<sup><xref ref-type="bibr" rid="cit6a">6a</xref></sup> thus, we first carried out the reaction of 2-fluoro-<italic>N</italic>-methylbenzamide (<bold>1a</bold>) with benzamide (<bold>2a</bold>, 2.5 equiv) in the presence of K<sub>2</sub>CO<sub>3</sub> (4.0 equiv) in DMSO. After 24 h at 135 &#x000b0;C, on the basis of
the analysis of the reaction mixture by gas chromatography&#x02013;mass
spectrometry (GC&#x02013;MS), only a trace amount of 3-methyl-2-phenylquinazolin-4-one
(<bold>3aa</bold>) was formed (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, entry 1). The reaction was then repeated in the presence
of KOH (4.0 equiv) because Bolm&#x02019;s group established intramolecular
N-arylations of <italic>N</italic>-(2-haloaryl)ureas to form benzimidazol-2-ones
under the conditions of KOH (2.0 equiv)/DMSO;<sup><xref ref-type="bibr" rid="ref9">9</xref></sup><bold>3aa</bold> can be isolated from the reaction mixture in 10%
yield (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, entry
2), and in this case, the considerable amount of 2-hydroxy-<italic>N</italic>-methylbenzamide formed via the S<sub>N</sub>Ar reaction
of <bold>1a</bold> with KOH. The use of KO<sup><italic>t</italic></sup>Bu resulted in the similar yield of <bold>3aa</bold> as KOH employed
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, entry 3).
Fortunately, when Cs<sub>2</sub>CO<sub>3</sub> was used in DMSO, <bold>3aa</bold> could be obtained in 72% isolated yield (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, entry 4),<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> although the yields of <bold>3aa</bold> were not satisfactory
in other solvents, such as tetrahydrofuran (THF), 1,4-dioxane, and
DMF (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, entries
5&#x02013;7). The decrease of either <bold>2a</bold> (2.5 equiv to
1.5&#x02013;1.0 equiv) or Cs<sub>2</sub>CO<sub>3</sub> (4.0 equiv to
1.0&#x02013;0.5 equiv) resulted in the considerable decrease of yields
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, entries 8&#x02013;11).
In addition, it was found that 2.5 equiv of Cs<sub>2</sub>CO<sub>3</sub> was suitable for the present transformation as a similar and good
yield of <bold>3aa</bold> was achieved (70%, entry 12 vs entry 4).
As expected, Cs<sub>2</sub>CO<sub>3</sub> is found to be the essential
promoter for the formation of <bold>3aa</bold> in DMSO because its
absence led to no <bold>3aa</bold> formation at all (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, entry 13).</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Optimization of Reaction Conditions
for Quinazolin-4-one Synthesis<xref rid="t1fn1" ref-type="table-fn">a</xref></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao-2019-00699f_0005" id="GRAPHIC-d7e504-autogenerated" position="float"/><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">entry</th><th style="border:none;" align="center" char="."><bold>2a</bold> (equiv)</th><th style="border:none;" align="center">base (equiv)</th><th style="border:none;" align="center">solvent</th><th style="border:none;" align="center">yield (%)<xref rid="t1fn2" ref-type="table-fn">b</xref></th></tr></thead><tbody><tr><td style="border:none;" align="left">1</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">K<sub>2</sub>CO<sub>3</sub> (4)</td><td style="border:none;" align="left">DMSO</td><td style="border:none;" align="left">trace</td></tr><tr><td style="border:none;" align="left">2</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">KOH (4)</td><td style="border:none;" align="left">DMSO</td><td style="border:none;" align="left">10</td></tr><tr><td style="border:none;" align="left">3</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">KO<sup><italic>t</italic></sup>Bu (4)</td><td style="border:none;" align="left">DMSO</td><td style="border:none;" align="left">12</td></tr><tr><td style="border:none;" align="left">4</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">Cs<sub>2</sub>CO<sub>3</sub> (4)</td><td style="border:none;" align="left">DMSO</td><td style="border:none;" align="left">72</td></tr><tr><td style="border:none;" align="left">5</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">Cs<sub>2</sub>CO<sub>3</sub> (4)</td><td style="border:none;" align="left">THF</td><td style="border:none;" align="left">15</td></tr><tr><td style="border:none;" align="left">7</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">Cs<sub>2</sub>CO<sub>3</sub> (4)</td><td style="border:none;" align="left">dioxane</td><td style="border:none;" align="left">19</td></tr><tr><td style="border:none;" align="left">6</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">Cs<sub>2</sub>CO<sub>3</sub> (4)</td><td style="border:none;" align="left">DMF</td><td style="border:none;" align="left">25</td></tr><tr><td style="border:none;" align="left">8</td><td style="border:none;" align="char" char=".">1.0</td><td style="border:none;" align="left">Cs<sub>2</sub>CO<sub>3</sub> (4)</td><td style="border:none;" align="left">DMSO</td><td style="border:none;" align="left">61</td></tr><tr><td style="border:none;" align="left">9</td><td style="border:none;" align="char" char=".">1.5</td><td style="border:none;" align="left">Cs<sub>2</sub>CO<sub>3</sub> (4)</td><td style="border:none;" align="left">DMSO</td><td style="border:none;" align="left">65</td></tr><tr><td style="border:none;" align="left">10</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">Cs<sub>2</sub>CO<sub>3</sub> (0.5)</td><td style="border:none;" align="left">DMSO</td><td style="border:none;" align="left">33</td></tr><tr><td style="border:none;" align="left">11</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">Cs<sub>2</sub>CO<sub>3</sub> (1.0)</td><td style="border:none;" align="left">DMSO</td><td style="border:none;" align="left">55</td></tr><tr><td style="border:none;" align="left">12</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">Cs<sub>2</sub>CO<sub>3</sub> (2.5)</td><td style="border:none;" align="left">DMSO</td><td style="border:none;" align="left">70</td></tr><tr><td style="border:none;" align="left">13</td><td style="border:none;" align="char" char=".">2.5</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">DMSO</td><td style="border:none;" align="left">0</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Reactions were carried out using <bold>1a</bold> (1.0 mmol) and <bold>2a</bold>, base in 4.0 mL of solvent
in a sealed tube at 135 &#x000b0;C for 24 h.</p></fn><fn id="t1fn2"><label>b</label><p>Yields of <bold>3aa</bold> are isolated.</p></fn></table-wrap-foot></table-wrap><p>To evaluate the scope and limitations
of the present procedure,
the reactions of several <italic>ortho</italic>-fluorobenzamides with
a wide variety of amides were examined under the reaction conditions
indicated in entry 12 of <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>.</p><p>As concluded in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>, except for benzamide (<bold>2a</bold>), the annulation
of <bold>1a</bold> with other arylamides (<bold>2b&#x02013;2g</bold>) and heteroaryl
amides (<bold>2h</bold>) occurs smoothly to give the corresponding
quinazolin-4-one products (<bold>3ab&#x02013;3ah</bold>) in good isolated
yields. <italic>ortho</italic>-Fluorobenzamides bearing either the
electron-rich group (OMe, <bold>1b</bold>) or electron-poor group
(CF<sub>3</sub>, <bold>1c</bold>) undergoes the annulation reaction
affording <bold>3ba</bold>, <bold>3ca</bold>, and <bold>3cc</bold> in acceptable yields. <italic>ortho</italic>-Fluoro-<italic>N</italic>-(<italic>n</italic>-propyl)benzamides (<bold>1d</bold> and <bold>1e</bold>) show good reactivity to undergo the annulation with electron-rich
arylamides. In addition, both electron-rich and electron-poor arylamides,
as well as heteroaryl amides (<bold>2h</bold> and <bold>2i</bold>)
are efficiently annulated with <italic>ortho</italic>-fluorobenzamide
(<bold>1f</bold>) to give the corresponding quinazolin-4-one products
in good isolated yields (<bold>3fa</bold>, <bold>3fb</bold>, <bold>3fd</bold>, <bold>3fe</bold>, <bold>3fh</bold>, <bold>3fi</bold>,
and <bold>3fk</bold>). Note that the annulation reactions of <bold>1a</bold> and <bold>1d</bold> with <italic>ortho</italic>-iodobenzamide
(<bold>2f</bold>) or <italic>ortho</italic>-bromobenzamide (<bold>2g</bold>) proceed with high chemoselectivity to give the corresponding
quinazolin-4-ones [<bold>3af</bold>, <bold>3ag</bold>, <bold>3df</bold> (X-ray, see the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00699/suppl_file/ao9b00699_si_001.pdf">Supporting Information</ext-link>), and <bold>3dg</bold>] via the S<sub>N</sub>Ar reaction of the
C&#x02013;F bond in <bold>1a</bold> and <bold>1d</bold>, while the
C&#x02013;I and C&#x02013;Br bonds in <bold>2f</bold> and <bold>2g</bold> are untouched. The products having the C&#x02013;I or C&#x02013;Br
bond are very useful for their further functionalization through carbon&#x02013;halide
bond activation. Moreover, except for (hetero)aryl amides, acetamide
(<bold>2j</bold>) was also subjected for annulation reaction with <bold>1a</bold> to give <bold>3aj</bold> in high yields (78%). More importantly,
the reaction of 2-fluoro-<italic>N</italic>-(<italic>o</italic>-tolyl)benzamide
(<bold>1g</bold>) with <bold>2j</bold> produces <bold>3gf</bold> (methaqualone)
in 67% yield, providing an efficient and simple, one-pot protocol
for the synthesis of the marketed drug product of methaqualone. In
addition, we are also interested in the homocyclodimerization of <bold>1f</bold> under the same reaction conditions, as expected, the reaction
occurs smoothly to give <bold>3f</bold> in 92% yield.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Substrate Scope of Quinazolin-4-one
Synthesis<xref rid="t2fn1" ref-type="table-fn">a</xref></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao-2019-00699f_0006" id="GRAPHIC-d7e1018-autogenerated" position="float"/><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao-2019-00699f_0007" id="gr4" position="float"/><table-wrap-foot><fn id="t2fn1"><label>a</label><p>Reactions were carried out using <bold>1</bold> (1.0
mmol), <bold>2</bold> (2.5 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (2.5 mmol) in 4.0 mL of DMSO in a sealed tube at 135
&#x000b0;C for 24 h.</p></fn></table-wrap-foot></table-wrap><p>A plausible
mechanism for the formation of <bold>3aa</bold> is
shown in <xref rid="sch3" ref-type="scheme">Scheme <xref rid="sch3" ref-type="scheme">3</xref></xref>.
It involves the S<sub>N</sub>Ar reaction of <bold>1a</bold> with <bold>2a</bold> giving the intermediate of diamide <bold>4aa</bold>, which
undergoes the intramolecular nucleophilic addition promoted by the
base, and the final dehydration to afford <bold>3aa</bold>. <bold>4aa</bold> can be isolated from a reaction mixture of <bold>1a</bold> and <bold>2a</bold> under the similar reaction conditions as for
the formation of <bold>3aa</bold> but after a short reaction time
(12h, <bold>4aa</bold> 41%). As expected, <bold>4aa</bold> can be
converted into <bold>3aa</bold> in high yields (<xref rid="eq1" ref-type="disp-formula">eq <xref rid="eq1" ref-type="disp-formula">1</xref></xref>).<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao-2019-00699f_0001" id="e1" position="float"/><label>1</label></disp-formula></p><fig id="sch3" position="float"><label>Scheme 3</label><caption><title>Plausible Mechanism
for the Formation of Quinazolin-4-one</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao-2019-00699f_0004" id="gr3" position="float"/></fig></sec><sec id="sec3"><title>Conclusions</title><p>In conclusion, we have established a Cs<sub>2</sub>CO<sub>3</sub>-promoted synthesis of quinazolin-4-ones in
DMSO through S<sub>N</sub>Ar reaction of <italic>ortho</italic>-fluorobenzamides
with amides
followed by intramolecular cyclization, providing an alternative protocol
for the construction of the quinazolin-4-one ring. The significant
advantages of the present procedure include the formation of C&#x02013;N
under transition-metal-free conditions and the direct application
in the synthesis of marketed drug of methaqualone.</p></sec><sec id="sec4"><title>Experimental
Section</title><sec id="sec4.1"><title>General Information</title><p>All commercial reagents are analytically
pure and used without further purification. Nuclear magnetic resonance
(NMR) spectra were recorded using CDCl<sub>3</sub> and DMSO-<italic>d</italic><sub>6</sub> at 298 K. <sup>1</sup>H NMR (400 MHz) chemical
shifts (&#x003b4;) were referenced to internal standard tetramethylsilane
(for <sup>1</sup>H, &#x003b4; = 0.00 ppm). <sup>13</sup>C NMR (100 MHz)
chemical shifts were referenced to internal solvent CDCl<sub>3</sub> (for <sup>13</sup>C, &#x003b4; = 77.16 ppm) and DMSO-<italic>d</italic><sub>6</sub> (for <sup>13</sup>C, &#x003b4; = 39.52 ppm). Mass spectra
were obtained on a low-resolution GC&#x02013;MS spectrometer, and high-resolution
mass spectrometry (HRMS) spectra were recorded on a high-resolution
magnetic sector mass spectrometer with an electrospray ionization
(ESI) source. The melting points are uncorrected.</p><sec id="sec4.1.1"><title>Typical Experimental Procedure
for the Synthesis of 3-Methyl-2-phenylquinazolin-4(3<italic>H</italic>)-one (<bold>3aa</bold>)</title><p>To a 25 mL tube equipped
with a magnetic stirrer were added 2-fluoro-<italic>N</italic>-methylbenzamide
(<bold>1a</bold>) (153.1 mg, 1.0 mmol), benzamide (<bold>2a</bold>) (302.8 mg, 2.5 mmol), Cs<sub>2</sub>CO<sub>3</sub> (815.1 mg, 2.5
mmol), and the freshly distilled DMSO (4.0 mL) under nitrogen. The
tube was sealed and stirred at 135 &#x000b0;C for 24 h in an oil bath.
After the reaction mixture was cooled to room temperature, it was
poured into a solvent mixture of water (50.0 mL) and ethyl acetate
(20.0 mL), and the two phases were then separated. The aqueous layer
was extracted with ethyl acetate (3 &#x000d7; 20.0 mL). The combined
organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the solvent under reduced pressure, the residue
was purified by column chromatography on silica gel with petroleum
ether/ethyl acetate (gradient mixture ratio from 100:0 to 70:30) as
the eluent to afford <bold>3aa</bold> as a white solid (165.3 mg,
70%).</p></sec><sec id="sec4.1.2"><title>3-Methyl-2-phenylquinazolin-4(3<italic>H</italic>)-one (<bold>3aa</bold>)<sup><xref ref-type="bibr" rid="cit5k">5k</xref></sup></title><p>It is obtained
as a white solid (165.3 mg, 70%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.33 (d, <italic>J</italic> = 7.9 Hz, 1H), 7.81&#x02013;7.70
(m, 2H), 7.61&#x02013;7.45 (m, 6H), 3.49 (s, 3H); <sup>13</sup>C NMR
(100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.8, 156.2, 147.4, 135.5, 134.4,
130.1, 129.0, 128.1, 127.16, 127.6, 126.8, 120.6, 34.3; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 236 (M<sup>+</sup>).</p></sec><sec id="sec4.1.3"><title>3-Methyl-2-(<italic>o</italic>-tolyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3ab</bold>)<sup><xref ref-type="bibr" rid="cit5j">5j</xref></sup></title><p>It
is obtained as a white solid (182.7 mg, 73%); <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>): &#x003b4; 8.33 (d, <italic>J</italic> = 7.9
Hz, 1H), 7.79&#x02013;7.26 (m, 2H), 7.49 (t, <italic>J</italic> = 6.4
Hz, 1H), 7.42&#x02013;7.27 (m, 4H), 3.32 (s, 3H), 2.23 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.4, 156.0,
147.3, 135.2, 135.1, 134.3, 130.7, 129.8, 127.5 (2C), 127.0, 126.7,
126.5, 120.7, 32.7, 19.1; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 250 (M<sup>+</sup>).</p></sec><sec id="sec4.1.4"><title>3-Methyl-2-(<italic>p</italic>-tolyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3ac</bold>)<sup><xref ref-type="bibr" rid="cit5k">5k</xref></sup></title><p>It
is obtained as a white solid (187.7 mg, 75%); <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>): &#x003b4; 8.30 (d, <italic>J</italic> = 8.0
Hz, 1H), 7.76&#x02013;7.67 (m, 2H), 7.51&#x02013;7.42 (m, 3H), 7.31
(d, <italic>J</italic> = 7.9 Hz, 2H), 3.49 (s, 3H), 2.42 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.8, 156.3,
147.4, 140.3, 134.2, 132.6, 129.5, 128.0, 127.5, 126.8, 126.7, 120.5,
34.3, 21.5; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 250
(M<sup>+</sup>).</p></sec><sec id="sec4.1.5"><title>2-(4-Methoxyphenyl)-3-methylquinazolin-4(3<italic>H</italic>)-one (<bold>3ad</bold>)<sup><xref ref-type="bibr" rid="cit6e">6e</xref></sup></title><p>It
is obtained as a white solid (154.4 mg, 58%); <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>): &#x003b4; 8.32 (d, <italic>J</italic> = 7.9
Hz, 1H), 7.80&#x02013;7.69 (m, 2H), 7.53 (d, <italic>J</italic> = 8.7
Hz, 2H), 7.49 (t, <italic>J</italic> = 6.9 Hz, 1H), 7.03 (d, <italic>J</italic> = 8.7 Hz, 2H), 3.88 (s, 3H), 3.53 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 163.1, 161.1, 156.1, 147.5,
134.3, 129.9, 127.9, 127.5, 126.9, 126.8, 120.5, 114.3, 55.6, 34.5;
GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 266 (M<sup>+</sup>).</p></sec><sec id="sec4.1.6"><title>3-Methyl-2-(naphthalen-2-yl)quinazolin-4(3<italic>H</italic>)-one (<bold>3ae</bold>)<sup><xref ref-type="bibr" rid="cit5k">5k</xref></sup></title><p>It
is obtained as a white solid (174.6 mg, 61%); <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>): &#x003b4; 8.36 (d, <italic>J</italic> = 7.9
Hz, 1H), 8.10 (s, 1H), 8.03&#x02013;7.88 (m, 3H), 7.77 (d, <italic>J</italic> = 3.8 Hz, 2H), 7.65&#x02013;7.48 (m, 4H), 3.54 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.9, 156.2,
147.5, 134.4, 133.8, 133.0, 132.8, 128.8, 128.6, 128.2, 127.9, 127.67,
127.62, 127.1 (2C), 126.8, 124.8, 120.7, 34.4; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 286 (M<sup>+</sup>).</p></sec><sec id="sec4.1.7"><title>2-(2-Iodophenyl)-3-methylquinazolin-4(3<italic>H</italic>)-one
(<bold>3af</bold>)</title><p>It is obtained as a white solid (246.2
mg, 68%); mp 112&#x02013;114 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.35 (d, <italic>J</italic> = 8.2 Hz, 1H), 7.94
(d, <italic>J</italic> = 8.0 Hz, 1H), 7.81&#x02013;7.70 (m, 2H), 7.57&#x02013;7.47
(m, 2H), 7.41 (d, <italic>J</italic> = 6.3 Hz, 1H), 7.20 (t, <italic>J</italic> = 7.7 Hz, 1H), 3.36 (s, 3H); <sup>13</sup>C NMR (100 MHz,
CDCl<sub>3</sub>): &#x003b4; 162.3, 156.3, 147.3, 140.7, 139.5, 134.4,
131.1, 128.9, 128.8, 127.7, 127.4, 126.8, 121.0, 95.7, 32.7; HRMS
(ESI) <italic>m</italic>/<italic>z</italic>: [M + H]<sup>+</sup> calcd
for C<sub>15</sub>H<sub>11</sub>IN<sub>2</sub>O, 362.9989; found,
362.9993.</p></sec><sec id="sec4.1.8"><title>2-(2-Bromophenyl)-3-methylquinazolin-4(3<italic>H</italic>)-one
(<bold>3ag</bold>)</title><p>It is obtained as a white solid (201.7
mg, 64%); mp 139&#x02013;141 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.34 (d, <italic>J</italic> = 8.1 Hz, 1H), 7.78&#x02013;7.72
(m, 2H), 7.69 (d, <italic>J</italic> = 8.1 Hz, 1H), 7.53&#x02013;7.44
(m, 3H), 7.37 (t, <italic>J</italic> = 7.4 Hz, 1H), 3.38 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.2, 154.6,
147.3, 136.7, 134.4, 133.1, 131.3, 129.5, 128.2, 127.6, 127.4, 126.8,
121.6, 121.0, 32.5; HRMS (ESI) <italic>m</italic>/<italic>z</italic>: [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>11</sub>BrN<sub>2</sub>O, 315.0128; found, 315.0135.</p></sec><sec id="sec4.1.9"><title>7-Methoxy-3-methyl-2-phenylquinazolin-4(3<italic>H</italic>)-one
(<bold>3ba</bold>)<sup><xref ref-type="bibr" rid="cit5k">5k</xref></sup></title><p>It is obtained
as a white solid (135.8 mg, 51%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.20 (d, <italic>J</italic> = 8.8 Hz, 1H), 7.58&#x02013;7.48
(m, 5H), 7.11 (s, 1H), 7.06 (d, <italic>J</italic> = 8.8 Hz, 1H),
3.88 (s, 3H), 3.46 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 164.6, 162.3, 156.9, 149.6, 135.6, 130.1, 128.9,
128.3, 128.0, 117.4, 114.1, 107.9, 55.7, 34.1; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 266 (M<sup>+</sup>).</p></sec><sec id="sec4.1.10"><title>3-Methyl-2-phenyl-7-(trifluoromethyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3ca</bold>)</title><p>It is obtained as waxy
oil (145.9
mg, 48%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.42
(d, <italic>J</italic> = 8.3 Hz, 1H), 8.01 (s, 1H), 7.68 (d, <italic>J</italic> = 8.3 Hz, 1H), 7.60&#x02013;7.52 (m, 5H), 3.52 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.1, 157.6,
147.3, 136.0 (q, <italic>J</italic> = 33.0 Hz), 135.0, 130.5, 129.1,
128.1, 120.0, 125.2 (q, <italic>J</italic> = 4.0 Hz), 123.5 (q, <italic>J</italic> = 271.0 Hz), 123.0 (q, <italic>J</italic> = 3.0 Hz), 122.8,
34.6; HRMS (ESI) <italic>m</italic>/<italic>z</italic>: [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>O, 305.0896; found, 305.0895.</p></sec><sec id="sec4.1.11"><title>3-Methyl-2-(<italic>p</italic>-tolyl)-7-(trifluoromethyl)quinazolin-4(3<italic>H</italic>)-one
(<bold>3cc</bold>)</title><p>It is obtained as waxy
oil (174.3 mg, 55%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>):
&#x003b4; 8.42 (d, <italic>J</italic> = 8.3 Hz, 1H), 8.02 (s, 1H), 7.68
(d, <italic>J</italic> = 8.3 Hz, 1H), 7.47 (d, <italic>J</italic> =
8.1 Hz, 2H), 7.34 (d, <italic>J</italic> = 8.0 Hz, 2H), 3.54 (s, 3H),
2.45 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4;
162.2, 157.8, 147.6, 140.9, 135.9 (q, <italic>J</italic> = 32.7 Hz),
132.2, 129.7, 128.1, 128.0, 125.2 (q, <italic>J</italic> = 4.0 Hz),
123.6 (q, <italic>J</italic> = 272.0 Hz), 122.9 (q, <italic>J</italic> = 3.0 Hz), 122.8, 34.7, 21.5; HRMS (ESI) <italic>m</italic>/<italic>z</italic>: [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O, 319.1053; found, 319.1058.</p></sec><sec id="sec4.1.12"><title>2-Phenyl-3-propylquinazolin-4(3<italic>H</italic>)-one (<bold>3da</bold>)<sup><xref ref-type="bibr" rid="ref11">11</xref></sup></title><p>It is obtained
as a white solid (163.8 mg, 62%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.33 (d, <italic>J</italic> = 8.7 Hz, 1H), 7.78&#x02013;7.70
(m, 2H), 7.54&#x02013;7.46 (m, 6H), 3.93 (t, <italic>J</italic> = 7.6
Hz, 2H), 1.69&#x02013;1.57 (m, 2H), 0.76 (t, <italic>J</italic> = 7.4
Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.2,
156.3, 147.2, 135.7, 134.4, 129.9, 128.8, 127.8, 127.5, 127.0, 126.8,
121.0, 47.5, 22.2, 11.2; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 264 (M<sup>+</sup>).</p></sec><sec id="sec4.1.13"><title>3-Propyl-2-(<italic>o</italic>-tolyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3db</bold>)</title><p>It is obtained as a white
solid
(180.9 mg, 65%); mp 89&#x02013;91 &#x000b0;C; <sup>1</sup>H NMR (400 MHz,
CDCl<sub>3</sub>): &#x003b4; 8.34 (d, <italic>J</italic> = 8.1 Hz, 1H),
7.80&#x02013;7.69 (m, 2H), 7.50 (t, <italic>J</italic> = 8.1 Hz, 1H),
7.44&#x02013;7.28 (m, 4H), 4.18&#x02013;4.06 (m, 1H), 3.51&#x02013;3.39
(m, 1H), 2.23 (s, 3H), 1.74&#x02013;1.42 (m, 2H), 0.74 (t, <italic>J</italic> = 7.4 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.1, 155.9, 147.4, 135.4, 135.0, 134.3, 130.7, 129.8,
127.8, 127.5, 127.0, 126.8, 126.2, 121.1, 47.0, 21.9, 19.3, 11.3;
HRMS (ESI) <italic>m</italic>/<italic>z</italic>: [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>18</sub>N<sub>2</sub>O, 279.1492;
found, 279.1495.</p></sec><sec id="sec4.1.14"><title>3-Propyl-2-(<italic>p</italic>-tolyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3dc</bold>)<sup><xref ref-type="bibr" rid="ref11">11</xref></sup></title><p>It
is obtained as a white solid (197.6 mg, 71%); <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>): &#x003b4; 8.32 (d, <italic>J</italic> = 7.9
Hz, 1H), 7.79&#x02013;7.67 (m, 2H), 7.49 (t, <italic>J</italic> = 7.1
Hz, 1H), 7.41 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.31 (d, <italic>J</italic> = 7.9 Hz, 2H), 3.95 (t, <italic>J</italic> = 8.0 Hz, 2H),
2.44 (s, 3H), 1.71&#x02013;1.58 (m, 2H), 0.77 (t, <italic>J</italic> = 7.4 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4;
162.4, 156.6, 147.3, 140.0, 134.3, 132.9, 129.5, 127.8, 127.5, 126.9,
126.8, 121.0, 47.6, 22.2, 21.5, 11.3; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 278 (M<sup>+</sup>).</p></sec><sec id="sec4.1.15"><title>2-(4-Methoxyphenyl)-3-propylquinazolin-4(3<italic>H</italic>)-one (<bold>3dd</bold>)</title><p>It is obtained as a white
solid
(182.4 mg, 62%); mp 65&#x02013;67 &#x000b0;C; <sup>1</sup>H NMR (400 MHz,
CDCl<sub>3</sub>): &#x003b4; 8.32 (d, <italic>J</italic> = 7.9 Hz, 1H),
7.77&#x02013;7.68 (m, 2H), 7.52&#x02013;7.44 (m, 3H), 7.02 (d, <italic>J</italic> = 8.7 Hz, 2H), 3.98 (t, <italic>J</italic> = 7.6 Hz, 2H),
3.88 (s, 3H), 1.70&#x02013;1.56 (m, 2H), 0.78 (t, <italic>J</italic> = 7.4 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4;
162.5, 160.7, 156.3, 147.3, 134.3, 129.5, 128.2, 127.5, 126.95, 126.90,
120.9, 114.2, 55.6, 47.6, 22.2, 11.3; HRMS (ESI) <italic>m</italic>/<italic>z</italic> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>, 295.1441; found, 295.1446.</p></sec><sec id="sec4.1.16"><title>2-(2-Iodophenyl)-3-propylquinazolin-4(3<italic>H</italic>)-one
(<bold>3df</bold>)</title><p>It is obtained as a white solid (269.2
mg, 69%); mp 110&#x02013;112 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.35 (d, <italic>J</italic> = 7.9 Hz, 1H), 7.94
(d, <italic>J</italic> = 8.0 Hz, 1H), 7.81&#x02013;7.70 (m, 2H), 7.55&#x02013;7.47
(m, 2H), 7.44 (d, <italic>J</italic> = 8.9 Hz, 1H), 7.20 (t, <italic>J</italic> = 7.7 Hz, 1H), 4.26&#x02013;5.15 (m, 1H), 3.42&#x02013;3.31
(m, 1H), 1.83&#x02013;1.67 (m, 1H), 1.56&#x02013;1.43 (m, 1H), 0.76
(t, <italic>J</italic> = 7.4 Hz, 1H); <sup>13</sup>C NMR (100 MHz,
CDCl<sub>3</sub>): &#x003b4; 162.0, 156.2, 147.2, 140.3, 139.4, 134.4,
131.1, 129.2, 128.5, 127.6, 127.3, 126.9, 121.3, 96.4, 47.4, 22.0,
11.4; HRMS (ESI) <italic>m</italic>/<italic>z</italic>: [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>15</sub>IN<sub>2</sub>O, 391.0302;
found, 391.0308.</p></sec><sec id="sec4.1.17"><title>2-(2-Bromophenyl)-3-propylquinazolin-4(3<italic>H</italic>)-one
(<bold>3dg</bold>)</title><p>It is obtained as a white solid (253.9
mg, 74%); mp 83&#x02013;85 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.36 (d, <italic>J</italic> = 8.1 Hz, 1H), 7.80&#x02013;7.72
(m, 2H), 7.70 (d, <italic>J</italic> = 8.0 Hz, 1H), 7.53 (t, <italic>J</italic> = 8.0 Hz, 1H), 7.49 (d, <italic>J</italic> = 4.4 Hz, 2H),
7.42&#x02013;7.35 (m, 1H), 4.28&#x02013;4.17 (m, 1H), 3.49&#x02013;3.36
(m, 1H), 1.81&#x02013;1.65 (m, 1H), 1.57&#x02013;1.41 (m, 1H), 0.77
(t, <italic>J</italic> = 7.4 Hz, 3H); <sup>13</sup>C NMR (100 MHz,
CDCl<sub>3</sub>): &#x003b4; 161.9, 154.5, 147.2, 136.5, 134.4, 133.1,
131.3, 129.9, 127.8, 127.6, 127.3, 126.9, 121.9, 121.3, 47.2, 22.0,
11.4; HRMS (ESI) <italic>m</italic>/<italic>z</italic>: [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>15</sub>BrN<sub>2</sub>O, 343.0441;
found, 343.0450.</p></sec><sec id="sec4.1.18"><title>8-Methyl-3-propyl-2-(<italic>o</italic>-tolyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3eb</bold>)</title><p>It is obtained as a white
liquid (222.2 mg, 76%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.20 (d, <italic>J</italic> = 8.0 Hz, 1H), 7.59 (d, <italic>J</italic> = 7.3 Hz, 1H), 7.43&#x02013;7.29 (m, 5H), 4.16&#x02013;4.04
(m, 1H), 3.57&#x02013;3.34 (m, 1H), 2.57 (s, 3H), 2.25 (s, 3H), 1.74&#x02013;1.40
(m, 2H), 0.74 (t, <italic>J</italic> = 7.4 Hz, 3H); <sup>13</sup>C
NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.6, 154.3, 146.1, 136.2,
135.7, 135.5, 134.8, 130.6, 129.6, 128.1, 126.5, 126.0, 124.4, 121.1,
47.0, 21.9, 19.5, 17.5, 11.3; HRMS (ESI) <italic>m</italic>/<italic>z</italic>: [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>2</sub>O, 293.1648; found, 293.1650.</p></sec><sec id="sec4.1.19"><title>8-Methyl-3-propyl-2-(<italic>p</italic>-tolyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3ec</bold>)</title><p>It is obtained as a white
solid (236.8 mg, 81%); mp 91&#x02013;93 &#x000b0;C <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>): &#x003b4; 8.17 (d, <italic>J</italic> = 7.9
Hz, 1H), 7.58 (d, <italic>J</italic> = 7.2 Hz, 1H), 7.44 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.36 (t, <italic>J</italic> = 7.6 Hz, 1H),
7.31 (d, <italic>J</italic> = 7.9 Hz, 2H), 3.98 (t, <italic>J</italic> = 8 Hz, 2H), 2.58 (s, 3H), 2.45 (s, 3H), 1.68&#x02013;1.57 (m, 2H),
0.77 (t, <italic>J</italic> = 7.4 Hz, 3H); <sup>13</sup>C NMR (100
MHz, CDCl<sub>3</sub>): &#x003b4; 162.9, 155.0, 146.1, 139.8, 136.1,
134.8, 133.4, 129.3, 128.2, 126.4, 124.4, 120.9, 47.5, 22.2, 21.5,
17.4, 11.2.; HRMS (ESI) <italic>m</italic>/<italic>z</italic>: [M
+ H]<sup>+</sup> for C<sub>19</sub>H<sub>20</sub>N<sub>2</sub>O 293.1648,
found, 293.1652.</p></sec><sec id="sec4.1.20"><title>2-Phenylquinazolin-4(3<italic>H</italic>)-one
(<bold>3fa</bold>)<sup><xref ref-type="bibr" rid="cit5j">5j</xref></sup></title><p>It is obtained
as a white
solid (140.0 mg, 63%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 11.50 (s, 1H), 8.33 (d, <italic>J</italic> = 7.6 Hz, 1H),
8.28&#x02013;8.20 (m, 2H), 7.88&#x02013;7.77 (m, 2H), 7.64&#x02013;7.56
(m, 3H), 7.51 (t, <italic>J</italic> = 7.2 Hz, 1H); <sup>13</sup>C
NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 163.9, 151.8, 149.6, 135.0,
132.9, 131.8, 129.2, 128.1, 127.5, 126.9, 126.5, 121.0; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 222 (M<sup>+</sup>).</p></sec><sec id="sec4.1.21"><title>2-(<italic>o</italic>-Tolyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3fb</bold>)<sup><xref ref-type="bibr" rid="cit5j">5j</xref></sup></title><p>It
is obtained as a white solid (153.5mg, 65%); <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>): &#x003b4; 10.42 (s, 1H), 8.26 (d, <italic>J</italic> = 8.0 Hz, 1H), 7.80 (d, <italic>J</italic> = 3.8 Hz, 2H), 7.56 (d, <italic>J</italic> = 7.2 Hz, 1H), 7.53&#x02013;7.48 (m, 1H), 7.43 (t, <italic>J</italic> = 7.2 Hz, 1H), 7.38&#x02013;3.31 (m, 2H), 2.53 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.9, 153.5,
149.1, 136.9, 135.0, 133.7, 131.6, 130.7, 128.7, 128.0, 127.1, 126.5,
126.4, 120.9, 20.2; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 236 (M<sup>+</sup>).</p></sec><sec id="sec4.1.22"><title>2-(4-Methoxyphenyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3fd</bold>)<sup><xref ref-type="bibr" rid="cit6i">6i</xref></sup></title><p>It is obtained
as a white solid (151.3 mg, 60%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 11.47 (br s, 1H), 8.32 (d, <italic>J</italic> =
7.9 Hz, 1H), 8.23 (d, <italic>J</italic> = 8.8 Hz, 2H), 7.83&#x02013;7.73
(m, 2H), 7.52&#x02013;7.42 (m, 1H), 7.07 (d, <italic>J</italic> = 8.7
Hz, 2H), 3.91 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 164.0, 162.5, 151.5, 149.8, 143.1, 134.9, 129.2, 127.9,
126.4, 125.2, 120.7, 114.5, 55.6; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 252 (M<sup>+</sup>).</p></sec><sec id="sec4.1.23"><title>2-(Naphthalen-2-yl)quinazolin-4(3<italic>H</italic>)-one (<bold>3fe</bold>)</title><p>It is obtained as a white
solid (185.1 mg, 68%);
mp 211&#x02013;213 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x003b4; 12.67 (s, 1H), 8.83 (s, 1H), 8.31
(d, <italic>J</italic> = 8.6 Hz, 1H), 8.19 (d, <italic>J</italic> =
7.8 Hz, 1H), 8.10&#x02013;7.98 (m, 3H), 7.87 (t, <italic>J</italic> = 7.5 Hz, 1H), 7.80 (d, <italic>J</italic> = 8.0 Hz, 1H), 7.69&#x02013;7.59
(m, 2H), 7.54 (t, <italic>J</italic> = 7.4 Hz, 1H); <sup>13</sup>C
NMR (100 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x003b4; 162.3,
152.3, 148.7, 134.6, 134.1, 132.2, 129.9, 128.9, 128.2, 128.1, 127.9,
127.6, 127.4, 126.9, 126.6, 125.9, 124.5, 121.0; HRMS (ESI) <italic>m</italic>/<italic>z</italic>: [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>12</sub>N<sub>2</sub>O, 273.1022; found, 273.1028.</p></sec><sec id="sec4.1.24"><title>3-Methyl-2-(thiophen-2-yl)quinazolin-4(3<italic>H</italic>)-one
(<bold>3ah</bold>)<sup><xref ref-type="bibr" rid="cit6d">6d</xref></sup></title><p>It is obtained
as a white solid (133.2 mg, 55%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.29 (d, <italic>J</italic> = 8.0 Hz, 1H), 7.77&#x02013;7.67
(m, 2H), 7.55 (d, <italic>J</italic> = 5.0 Hz, 1H), 7.53&#x02013;7.44
(m, 2H), 7.16 (t, <italic>J</italic> = 4.0 Hz, 1H), 3.77 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4;.162.8, 150.1, 147.3,
137.2, 134.4, 129.8, 129.5, 127.5, 127.1, 126.8, 120.2, 34.2; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 242 (M<sup>+</sup>).</p></sec><sec id="sec4.1.25"><title>2-(Thiophen-2-yl)quinazolin-4(3<italic>H</italic>)-one (<bold>3fh</bold>)<sup><xref ref-type="bibr" rid="cit5j">5j</xref></sup></title><p>It is obtained
as a white solid (141.2 mg, 62%); <sup>1</sup>H NMR (400 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x003b4; 12.65 (s, 1H), 8.23 (d, <italic>J</italic> = 3.5 Hz, 1H), 8.12 (d, <italic>J</italic> = 7.7 Hz, 1H),
7.86 (d, <italic>J</italic> = 4.9 Hz, 1H), 7.79 (t, <italic>J</italic> = 7.4 Hz, 1H), 7.64 (d, <italic>J</italic> = 8.1 Hz, 1H), 7.48 (t, <italic>J</italic> = 7.5 Hz, 1H), 7.23 (t, <italic>J</italic> = 4.3 Hz, 1H); <sup>13</sup>C NMR (100 MHz, DMSO-<italic>d</italic><sub>6</sub>): &#x003b4;
161.8, 148.6, 147.8, 137.3, 134.6, 132.1, 129.4, 128.5, 126.8, 126.3,
125.9, 120.8; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>:
228 (M<sup>+</sup>).</p></sec><sec id="sec4.1.26"><title>2-(Pyridin-2-yl)quinazolin-4(3<italic>H</italic>)-one (<bold>3fi</bold>)<sup><xref ref-type="bibr" rid="cit6i">6i</xref></sup></title><p>It
is obtained
as a white solid (154.0 mg, 69%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 10.96 (s, 1H), 8.68 (d, <italic>J</italic> = 4.4
Hz, 1H), 8.59 (d, <italic>J</italic> = 7.9 Hz, 1H), 8.36 (d, <italic>J</italic> = 7.9 Hz, 1H), 7.92 (t, <italic>J</italic> = 7.7 Hz, 1H),
7.86&#x02013;7.76 (m, 2H), 7.56&#x02013;7.4 (m, 2H); <sup>13</sup>C
NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 161.5, 149.2, 149.0, 148.8,
148.5, 137.6, 134.7, 128.1, 127.4, 126.9, 126.3. 122.6, 122.1; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 223 (M<sup>+</sup>).</p></sec><sec id="sec4.1.27"><title>2,3-Dimethylquinazolin-4(3<italic>H</italic>)-one (<bold>3aj</bold>)<sup><xref ref-type="bibr" rid="cit5h">5h</xref></sup></title><p>It is obtained as a white
solid (135.8 mg, 78%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.58 (d, <italic>J</italic> = 7.9 Hz, 1H), 8.04 (t, <italic>J</italic> = 8.3 Hz, 1H), 7.93 (d, <italic>J</italic> = 8.1 Hz, 1H),
7.76 (t, <italic>J</italic> = 7.5 Hz, 1H), 3.95 (s, 3H), 2.94 (s,
3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.4,
154.5, 147.3, 134.2, 126.8, 126.7, 126.4, 120.3, 31.1, 23.7; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 174 (M<sup>+</sup>).</p></sec><sec id="sec4.1.28"><title>2-Methyl-3-(<italic>o</italic>-tolyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3gj</bold>, Methaqualone)<sup><xref ref-type="bibr" rid="ref11">11</xref></sup></title><p>It is obtained
as a white solid (167.5 mg, 67%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 8.28 (d, <italic>J</italic> = 7.9 Hz, 1H), 7.77
(t, <italic>J</italic> = 7.5 Hz, 1H), 7.69 (d, <italic>J</italic> =
8.1 Hz, 1H), 7.46 (t, <italic>J</italic> = 7.5 Hz, 1H),
7.41&#x02013;7.33 (m, 3H), 7.15 (d, <italic>J</italic> = 7.3 Hz, 1H),
2.18 (s, 3H), 2.12 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 161.7, 154.4, 147.7, 136.9, 135.4, 134.6, 129.6,
128.0, 127.7, 127.2, 126.8, 126.6, 120.8, 23.9, 17.4; GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 250 (M<sup>+</sup>).</p></sec><sec id="sec4.1.29"><title>2-(2-Fluorophenyl)quinazolin-4(3<italic>H</italic>)-one (<bold>3f</bold>)<sup><xref ref-type="bibr" rid="cit5j">5j</xref></sup></title><p>It is obtained as
a white solid (110.4 mg, 92%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 10.68 (s, 1H), 8.25 (d, <italic>J</italic> = 7.9
Hz, 1H), 8.20 (t, <italic>J</italic> = 7.8 Hz, 1H), 7.81&#x02013;7.71
(m, 2H), 7.54&#x02013;7.44 (m, 2H), 7.29 (t, <italic>J</italic> = 7.6
Hz, 1H), 7.23&#x02013;7.14 (m, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 162.3, 160.7 (d, <italic>J</italic> = 249.0 Hz),
149.0, 148.6 (d, <italic>J</italic> = 10.0 Hz), 134.8, 133.4 (d, <italic>J</italic> = 9.0 Hz), 131.3 (d, <italic>J</italic> = 1.0 Hz), 128.0,
127.2, 126.5, 125.1 (d, <italic>J</italic> = 3.0 Hz), 121.2, 120.1
(d, <italic>J</italic> = 10.0 Hz), 116.6 (d, <italic>J</italic> =
22.0 Hz); GC&#x02013;MS <italic>m</italic>/<italic>z</italic>: 240
(M<sup>+</sup>).</p></sec><sec id="sec4.1.30"><title>2-Benzamido-<italic>N</italic>-methylbenzamide
(<bold>4aa</bold>)</title><p>It is obtained as a light yellow solid;
mp 163&#x02013;165
&#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 12.08
(s, 1H), 8.66 (d, <italic>J</italic> = 8.5 Hz, 1H), 8.02 (d, <italic>J</italic> = 7.4 Hz, 2H), 7.64&#x02013;7.37 (m, 5H), 6.95 (t, <italic>J</italic> = 7.6 Hz, 1H), 6.85 (br s, 1H), 2.99 (d, <italic>J</italic> = 4.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4;
169.9, 165.9, 139.5, 134.8, 132.3, 132.0, 128.9, 127.4, 126.8, 123.0,
121.6, 120.9, 26.9; HRMS (ESI) <italic>m</italic>/<italic>z</italic>: [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>, 255.1128; found, 255.1125.</p></sec></sec></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information is
available free of charge on the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org">ACS Publications website</ext-link> at DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/abs/10.1021/acsomega.9b00699">10.1021/acsomega.9b00699</ext-link>.<list id="silist" list-type="simple"><list-item><p>Copies of <sup>1</sup>H and <sup>13</sup>C NMR charts
of all products and X-ray structural details of <bold>3df</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b00699/suppl_file/ao9b00699_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao9b00699_si_001.pdf"><caption><p>ao9b00699_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="COI-statement" id="NOTES-d7e2733-autogenerated"><p>The authors declare no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>This project was supported by the National
Natural
Science Foundation of China (21673124, 21473097). M.A.I., D.M.K.,
and H.M. thank the China Scholarship Council (CSC) for generous support
for their study in Tsinghua University as PhD candidates.</p></ack><ref-list><title>References</title><ref id="ref1"><note><p>Selected review
papers, see:</p></note><mixed-citation publication-type="journal" id="cit1a"><label>a</label><name><surname>Michael</surname><given-names>J. P.</given-names></name>
<article-title>Quinoline,
quinazoline and acridone alkaloids</article-title>. <source>Nat. Prod.
Rep.</source>
<year>2004</year>, <volume>21</volume>, <fpage>650</fpage>&#x02013;<lpage>668</lpage><pub-id pub-id-type="doi">10.1039/b310691h</pub-id>.<pub-id pub-id-type="pmid">15459759</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit1b"><label> b</label><name><surname>Mhaske</surname><given-names>S. B.</given-names></name>; <name><surname>Argade</surname><given-names>N. P.</given-names></name>
<article-title>The chemistry of recently isolated
naturally occurring quinazolinone alkaloids</article-title>. <source>Tetrahedron</source>
<year>2006</year>, <volume>62</volume>, <fpage>9787</fpage>&#x02013;<lpage>9826</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2006.07.098</pub-id>.</mixed-citation></ref><ref id="ref2"><note><p>Selected reports:</p></note><mixed-citation publication-type="journal" id="cit2a"><label>a</label><name><surname>Kikuchi</surname><given-names>H.</given-names></name>; <name><surname>Yamamoto</surname><given-names>K.</given-names></name>; <name><surname>Horoiwa</surname><given-names>S.</given-names></name>; <name><surname>Hirai</surname><given-names>S.</given-names></name>; <name><surname>Kasahara</surname><given-names>R.</given-names></name>; <name><surname>Hariguchi</surname><given-names>N.</given-names></name>; <name><surname>Matsumoto</surname><given-names>M.</given-names></name>; <name><surname>Oshima</surname><given-names>Y.</given-names></name>
<article-title>Exploration of a new
type of antimalarial compounds based on febrifugine</article-title>. <source>J. Med. Chem.</source>
<year>2006</year>, <volume>49</volume>, <fpage>4698</fpage>&#x02013;<lpage>4706</lpage><pub-id pub-id-type="doi">10.1021/jm0601809</pub-id>.<pub-id pub-id-type="pmid">16854076</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit2b"><label> b</label><name><surname>Balakumar</surname><given-names>C.</given-names></name>; <name><surname>Lamba</surname><given-names>P.</given-names></name>; <name><surname>Pran Kishore</surname><given-names>D.</given-names></name>; <name><surname>Lakshmi Narayana</surname><given-names>B.</given-names></name>; <name><surname>Venkat Rao</surname><given-names>K.</given-names></name>; <name><surname>Rajwinder</surname><given-names>K.</given-names></name>; <name><surname>Raghuram Rao</surname><given-names>A.</given-names></name>; <name><surname>Shireesha</surname><given-names>B.</given-names></name>; <name><surname>Narsaiah</surname><given-names>B.</given-names></name>
<article-title>Synthesis, anti-inflammatory
evaluation and docking studies of some new fluorinated fused quinazolines</article-title>. <source>Eur. J. Med. Chem.</source>
<year>2010</year>, <volume>45</volume>, <fpage>4904</fpage>&#x02013;<lpage>4913</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2010.07.063</pub-id>.<pub-id pub-id-type="pmid">20800934</pub-id></mixed-citation></ref><ref id="ref3"><note><p>Selected recent reports, see:</p></note><mixed-citation publication-type="journal" id="cit3a"><label>a</label><name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Jiao</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>K.</given-names></name>; <name><surname>Zhang</surname><given-names>X.</given-names></name>; <name><surname>Zhao</surname><given-names>L.</given-names></name>; <name><surname>Liu</surname><given-names>D.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>
<article-title>Direct access to pyrido/pyrrolo[2,1-b]quinazolin-9(1H)-ones
through silver-mediated intramolecular alkyne hydroamination reactions</article-title>. <source>Beilstein J. Org. Chem.</source>
<year>2015</year>, <volume>11</volume>, <fpage>416</fpage>&#x02013;<lpage>424</lpage><pub-id pub-id-type="doi">10.3762/bjoc.11.47</pub-id>.<pub-id pub-id-type="pmid">25977715</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit3b"><label> b</label><name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Tan</surname><given-names>H.</given-names></name>; <name><surname>Sun</surname><given-names>Q.</given-names></name>; <name><surname>Ge</surname><given-names>Z.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>R.</given-names></name>
<article-title>Design, synthesis and
biological evaluation of pyridazino[3,4,5-de]quinazolin-3(2<italic>H</italic>)-one as a new class of PARP-1 inhibitors</article-title>. <source>Bioorg. Med. Chem. Lett.</source>
<year>2015</year>, <volume>25</volume>, <fpage>2340</fpage>&#x02013;<lpage>2344</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2015.04.013</pub-id>.<pub-id pub-id-type="pmid">25899312</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit3c"><label> c</label><name><surname>Sun</surname><given-names>M.</given-names></name>; <name><surname>Zhao</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Zong</surname><given-names>Z.</given-names></name>; <name><surname>Han</surname><given-names>J.</given-names></name>; <name><surname>Du</surname><given-names>Y.</given-names></name>; <name><surname>Sun</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>F.</given-names></name>
<article-title>Synthesis and biological evaluation
of novel tricyclic oxazine and oxazepine fused quinazolines. Part
2: Gefitinib analogs</article-title>. <source>Bioorg. Med. Chem. Lett.</source>
<year>2016</year>, <volume>26</volume>, <fpage>4842</fpage>&#x02013;<lpage>4845</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2016.08.007</pub-id>.<pub-id pub-id-type="pmid">27524310</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit3d"><label> d</label><name><surname>OuYang</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>C.</given-names></name>; <name><surname>Zhao</surname><given-names>B.</given-names></name>; <name><surname>Xiong</surname><given-names>H.</given-names></name>; <name><surname>Xiao</surname><given-names>Z.</given-names></name>; <name><surname>Zhang</surname><given-names>B.</given-names></name>; <name><surname>Zheng</surname><given-names>P.</given-names></name>; <name><surname>Hu</surname><given-names>J.</given-names></name>; <name><surname>Gao</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>M.</given-names></name>; <name><surname>Zhu</surname><given-names>W.</given-names></name>; <name><surname>Xu</surname><given-names>S.</given-names></name>
<article-title>Design, synthesis,
antiproliferative activity and docking studies of quinazoline derivatives
bearing oxazole or imidazole as potential EGFR inhibitors</article-title>. <source>New J. Chem.</source>
<year>2018</year>, <volume>42</volume>, <fpage>17203</fpage>&#x02013;<lpage>17215</lpage><pub-id pub-id-type="doi">10.1039/c8nj03594f</pub-id>.</mixed-citation></ref><ref id="ref4"><note><p>Selected review papers,
see:</p></note><mixed-citation publication-type="journal" id="cit4a"><label>a</label><name><surname>Connolly</surname><given-names>D. J.</given-names></name>; <name><surname>Cusack</surname><given-names>D.</given-names></name>; <name><surname>O&#x02019;Sullivan</surname><given-names>T.
P.</given-names></name>; <name><surname>Guiry</surname><given-names>P. J.</given-names></name>
<article-title>Synthesis
of quinazolinones and quinazolines</article-title>. <source>Tetrahedron</source>
<year>2005</year>, <volume>61</volume>, <fpage>10153</fpage>&#x02013;<lpage>10202</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2005.07.010</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit4b"><label> b</label><name><surname>Ugale</surname><given-names>V. G.</given-names></name>; <name><surname>Bari</surname><given-names>S. B.</given-names></name>
<article-title>Quinazolines: New horizons in anticonvulsant
therapy</article-title>. <source>Eur. J. Med. Chem.</source>
<year>2014</year>, <volume>80</volume>, <fpage>447</fpage>&#x02013;<lpage>501</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2014.04.072</pub-id>.<pub-id pub-id-type="pmid">24813877</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit4c"><label> c</label><name><surname>He</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Chen</surname><given-names>J.</given-names></name>; <name><surname>Wu</surname><given-names>X.-F.</given-names></name>
<article-title>Recent advances in 4(3<italic>H</italic>)-quinazolinone syntheses</article-title>. <source>RSC Adv.</source>
<year>2014</year>, <volume>4</volume>, <fpage>12065</fpage>&#x02013;<lpage>12077</lpage><pub-id pub-id-type="doi">10.1039/c4ra00351a</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit4d"><label> d</label><name><surname>Khan</surname><given-names>I.</given-names></name>; <name><surname>Ibrar</surname><given-names>A.</given-names></name>; <name><surname>Ahmed</surname><given-names>W.</given-names></name>; <name><surname>Saeed</surname><given-names>A.</given-names></name>
<article-title>Synthetic approaches,
functionalization and therapeutic potential of quinazoline and quinazolinone
skeletons: the advances continue</article-title>. <source>Eur. J. Med.
Chem.</source>
<year>2015</year>, <volume>90</volume>, <fpage>124</fpage>&#x02013;<lpage>169</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2014.10.084</pub-id>.<pub-id pub-id-type="pmid">25461317</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit4e"><label> e</label><name><surname>Kshirsagar</surname><given-names>U. A.</given-names></name>
<article-title>Recent developments in the chemistry
of quinazolinone alkaloids</article-title>. <source>Org. Biomol. Chem.</source>
<year>2015</year>, <volume>13</volume>, <fpage>9336</fpage>&#x02013;<lpage>9352</lpage><pub-id pub-id-type="doi">10.1039/c5ob01379h</pub-id>.<pub-id pub-id-type="pmid">26278395</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit4f"><label> f</label><name><surname>Kshirsagar</surname><given-names>U.</given-names></name>; <name><surname>Rohokale</surname><given-names>R.</given-names></name>
<article-title>Advanced synthetic strategies for constructing quinazolinone
scaffolds</article-title>. <source>Synthesis</source>
<year>2016</year>, <volume>48</volume>, <fpage>1253</fpage>&#x02013;<lpage>1268</lpage><pub-id pub-id-type="doi">10.1055/s-0035-1560413</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit4g"><label> g</label><name><surname>Khan</surname><given-names>I.</given-names></name>; <name><surname>Zaib</surname><given-names>S.</given-names></name>; <name><surname>Batool</surname><given-names>S.</given-names></name>; <name><surname>Abbas</surname><given-names>N.</given-names></name>; <name><surname>Ashraf</surname><given-names>Z.</given-names></name>; <name><surname>Iqbal</surname><given-names>J.</given-names></name>; <name><surname>Saeed</surname><given-names>A.</given-names></name>
<article-title>Quinazolines and quinazolinones as
ubiquitous structural fragments in medicinal chemistry: An update
on the development of synthetic methods and pharmacological diversification</article-title>. <source>Bioorg. Med. Chem.</source>
<year>2016</year>, <volume>24</volume>, <fpage>2361</fpage>&#x02013;<lpage>2381</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2016.03.031</pub-id>.<pub-id pub-id-type="pmid">27112448</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit4h"><label> h</label><name><surname>Maiden</surname><given-names>T. M. M.</given-names></name>; <name><surname>Harrity</surname><given-names>J. P. A.</given-names></name>
<article-title>Recent
developments in transition metal catalysis for quinazolinone synthesis</article-title>. <source>Org. Biomol. Chem.</source>
<year>2016</year>, <volume>14</volume>, <fpage>8014</fpage>&#x02013;<lpage>8025</lpage><pub-id pub-id-type="doi">10.1039/c6ob01402j</pub-id>.<pub-id pub-id-type="pmid">27477737</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit4i"><label> i</label><name><surname>Mathew</surname><given-names>T.</given-names></name>; <name><surname>Papp</surname><given-names>A. &#x000c1;.</given-names></name>; <name><surname>Paknia</surname><given-names>F.</given-names></name>; <name><surname>Fustero</surname><given-names>S.</given-names></name>; <name><surname>Surya Prakash</surname><given-names>G. K.</given-names></name>
<article-title>Benzodiazines:
recent synthetic advances</article-title>. <source>Chem. Soc. Rev.</source>
<year>2017</year>, <volume>46</volume>, <fpage>3060</fpage>&#x02013;<lpage>3094</lpage><pub-id pub-id-type="doi">10.1039/c7cs00082k</pub-id>.<pub-id pub-id-type="pmid">28452390</pub-id></mixed-citation></ref><ref id="ref5"><note><p>Selected reports on the syntheses of quinazolin-4-ones
from <italic>ortho</italic>-aminobenzamides, see:</p></note><mixed-citation publication-type="journal" id="cit5a"><label>a</label><name><surname>Zhu</surname><given-names>Y.-p.</given-names></name>; <name><surname>Fei</surname><given-names>Z.</given-names></name>; <name><surname>Liu</surname><given-names>M.-c.</given-names></name>; <name><surname>Jia</surname><given-names>F.-c.</given-names></name>; <name><surname>Wu</surname><given-names>A.-x.</given-names></name>
<article-title>Direct one-pot synthesis
of Luotonin F and analogues via rational logical design</article-title>. <source>Org. Lett.</source>
<year>2013</year>, <volume>15</volume>, <fpage>378</fpage>&#x02013;<lpage>381</lpage><pub-id pub-id-type="doi">10.1021/ol303331g</pub-id>.<pub-id pub-id-type="pmid">23273132</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit5b"><label> b</label><name><surname>Zhan</surname><given-names>D.</given-names></name>; <name><surname>Li</surname><given-names>T.</given-names></name>; <name><surname>Wei</surname><given-names>H.</given-names></name>; <name><surname>Weng</surname><given-names>W.</given-names></name>; <name><surname>Ghandi</surname><given-names>K.</given-names></name>; <name><surname>Zeng</surname><given-names>Q.</given-names></name>
<article-title>A recyclable CuO-catalyzed synthesis
of 4(3<italic>H</italic>)-quinazolinones</article-title>. <source>RSC
Adv.</source>
<year>2013</year>, <volume>3</volume>, <fpage>9325</fpage>&#x02013;<lpage>9329</lpage><pub-id pub-id-type="doi">10.1039/c3ra41370e</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit5c"><label> c</label><name><surname>Ge</surname><given-names>W.</given-names></name>; <name><surname>Zhu</surname><given-names>X.</given-names></name>; <name><surname>Wei</surname><given-names>Y.</given-names></name>
<article-title>Iodine-catalyzed oxidative
system for cyclization of primary alcohols with o-aminobenzamides
to quinazolinones using DMSO as the oxidant in dimethyl carbonate</article-title>. <source>RSC Adv.</source>
<year>2013</year>, <volume>3</volume>, <fpage>10817</fpage>&#x02013;<lpage>10822</lpage><pub-id pub-id-type="doi">10.1039/c3ra40872h</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit5d"><label> d</label><name><surname>Kim</surname><given-names>N. Y.</given-names></name>; <name><surname>Cheon</surname><given-names>C.-H.</given-names></name>
<article-title>Synthesis of quinazolinones from
anthranilamides and aldehydes <italic>via</italic> metal-free aerobic
oxidation in DMSO</article-title>. <source>Tetrahedron Lett.</source>
<year>2014</year>, <volume>55</volume>, <fpage>2340</fpage>&#x02013;<lpage>2344</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2014.02.065</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit5e"><label> e</label><name><surname>Zhao</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>T.</given-names></name>; <name><surname>Li</surname><given-names>J.-X.</given-names></name>
<article-title>Metal-free oxidative
synthesis of quinazolinones <italic>via</italic> dual amination of <italic>sp</italic><sup>3</sup> C&#x02013;H bonds</article-title>. <source>Chem.
Commun.</source>
<year>2014</year>, <volume>50</volume>, <fpage>6471</fpage>&#x02013;<lpage>6474</lpage><pub-id pub-id-type="doi">10.1039/c4cc02648a</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit5f"><label> f</label><name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Cheng</surname><given-names>G.</given-names></name>; <name><surname>Shen</surname><given-names>J.</given-names></name>; <name><surname>Kuai</surname><given-names>C.</given-names></name>; <name><surname>Cui</surname><given-names>X.</given-names></name>
<article-title>Cleavage of the C-C triple bond of ketoalkynes: synthesis of 4(3H)-quinazolinones</article-title>. <source>Org. Chem. Front.</source>
<year>2015</year>, <volume>2</volume>, <fpage>366</fpage>&#x02013;<lpage>368</lpage><pub-id pub-id-type="doi">10.1039/c4qo00260a</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit5g"><label> g</label><name><surname>Yan</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Niu</surname><given-names>B.</given-names></name>; <name><surname>Xie</surname><given-names>H.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>
<article-title>I2-Catalyzed Aerobic Oxidative C(sp3)-H Amination/C-N Cleavage of
Tertiary Amine: Synthesis of Quinazolines and Quinazolinones</article-title>. <source>J. Org. Chem.</source>
<year>2015</year>, <volume>80</volume>, <fpage>5581</fpage>&#x02013;<lpage>5587</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.5b00474</pub-id>.<pub-id pub-id-type="pmid">25942678</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit5h"><label> h</label><name><surname>Shen</surname><given-names>G.</given-names></name>; <name><surname>Zhou</surname><given-names>H.</given-names></name>; <name><surname>Du</surname><given-names>P.</given-names></name>; <name><surname>Liu</surname><given-names>S.</given-names></name>; <name><surname>Zou</surname><given-names>K.</given-names></name>; <name><surname>Uozumi</surname><given-names>Y.</given-names></name>
<article-title>Br&#x000f8;nsted acid-catalyzed
selective C-C bond cleavage of 1,3-diketones: a facile synthesis of
4(3H)-quinazolinones in aqueous ethyl lactate</article-title>. <source>RSC Adv.</source>
<year>2015</year>, <volume>5</volume>, <fpage>85646</fpage>&#x02013;<lpage>85651</lpage><pub-id pub-id-type="doi">10.1039/c5ra17969f</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit5i"><label> i</label><name><surname>Wang</surname><given-names>Z.-z.</given-names></name>; <name><surname>Tang</surname><given-names>Y.</given-names></name>
<article-title>Mechanistic insights into a catalyst-free
method to construct quinazolinones through multiple oxidative cyclization</article-title>. <source>Tetrahedron</source>
<year>2016</year>, <volume>72</volume>, <fpage>1330</fpage>&#x02013;<lpage>1336</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2016.01.027</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit5j"><label> j</label><name><surname>Yu</surname><given-names>Z.-Y.</given-names></name>; <name><surname>Chen</surname><given-names>M.-Y.</given-names></name>; <name><surname>He</surname><given-names>J.-X.</given-names></name>; <name><surname>Tao</surname><given-names>D.-J.</given-names></name>; <name><surname>Yuan</surname><given-names>J.-J.</given-names></name>; <name><surname>Peng</surname><given-names>Y.-Y.</given-names></name>; <name><surname>Song</surname><given-names>Z.-B.</given-names></name>
<article-title>Controllable Br&#x000f8;nsted
acid-promoted aerobic oxidation via solvation-induced proton transfer:
Metal-free construction of quinazolinones and dihydroquinazolinones</article-title>. <source>Mol. Catal.</source>
<year>2017</year>, <volume>434</volume>, <fpage>134</fpage>&#x02013;<lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.mcat.2017.03.006</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit5k"><label> k</label><name><surname>Qian</surname><given-names>C.</given-names></name>; <name><surname>Liu</surname><given-names>K.</given-names></name>; <name><surname>Tao</surname><given-names>S.-W.</given-names></name>; <name><surname>Zhang</surname><given-names>F.-L.</given-names></name>; <name><surname>Zhu</surname><given-names>Y.-M.</given-names></name>; <name><surname>Yang</surname><given-names>S.-L.</given-names></name>
<article-title>Palladium-Catalyzed Oxidative Three-Component
Coupling of Anthranilamides with Isocyanides and Arylboronic Acids:
Access to 2,3-Disubstituted Quinazolinones</article-title>. <source>J. Org. Chem.</source>
<year>2018</year>, <volume>83</volume>, <fpage>9201</fpage>&#x02013;<lpage>9209</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.8b01218</pub-id>.<pub-id pub-id-type="pmid">29961318</pub-id></mixed-citation></ref><ref id="ref6"><note><p>Selected reports on the
syntheses of quinazolin-4-ones
from <italic>ortho</italic>-halobenzamides, see:</p></note><mixed-citation publication-type="journal" id="cit6a"><label>a</label><name><surname>Xu</surname><given-names>W.</given-names></name>; <name><surname>Jin</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Jiang</surname><given-names>Y.</given-names></name>; <name><surname>Fu</surname><given-names>a. H.</given-names></name>
<article-title>Copper-Catalyzed
Domino Synthesis of Quinazolinones via Ullmann-Type Coupling and Aerobic
Oxidative C&#x02013;H Amidation</article-title>. <source>Org. Lett.</source>
<year>2011</year>, <volume>13</volume>, <fpage>1274</fpage>&#x02013;<lpage>1277</lpage><pub-id pub-id-type="doi">10.1021/ol1030266</pub-id>.<pub-id pub-id-type="pmid">21344914</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit6b"><label> b</label><name><surname>Xu</surname><given-names>W.</given-names></name>; <name><surname>Fu</surname><given-names>H.</given-names></name>
<article-title>Amino Acids as the Nitrogen-Containing Motifs in Copper-Catalyzed
Domino Synthesis of N-Heterocycles</article-title>. <source>J. Org.
Chem.</source>
<year>2011</year>, <volume>76</volume>, <fpage>3846</fpage>&#x02013;<lpage>3852</lpage><pub-id pub-id-type="doi">10.1021/jo2002227</pub-id>.<pub-id pub-id-type="pmid">21469687</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit6c"><label> c</label><name><surname>Xu</surname><given-names>L.</given-names></name>; <name><surname>Jiang</surname><given-names>Y.</given-names></name>; <name><surname>Ma</surname><given-names>D.</given-names></name>
<article-title>Synthesis of 3-substituted
and 2,3-disubstituted quinazolinones <italic>via</italic> Cu-catalyzed
aryl amidation</article-title>. <source>Org. Lett.</source>
<year>2012</year>, <volume>14</volume>, <fpage>1150</fpage>&#x02013;<lpage>1153</lpage><pub-id pub-id-type="doi">10.1021/ol300084v</pub-id>.<pub-id pub-id-type="pmid">22313025</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit6d"><label> d</label><name><surname>Guo</surname><given-names>S.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Tao</surname><given-names>L.</given-names></name>; <name><surname>Zhang</surname><given-names>W.</given-names></name>; <name><surname>Fan</surname><given-names>X.</given-names></name>
<article-title>Rapid assembly of quinazolinone
scaffold <italic>via</italic> copper-catalyzed tandem reaction of
2-bromobenzamides with aldehydes and aqueous ammonia: application
to the synthesis of the alkaloid tryptanthrin</article-title>. <source>RSC Adv.</source>
<year>2014</year>, <volume>4</volume>, <fpage>59289</fpage>&#x02013;<lpage>59296</lpage><pub-id pub-id-type="doi">10.1039/c4ra10799c</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit6e"><label> e</label><name><surname>Kotipalli</surname><given-names>T.</given-names></name>; <name><surname>Kavala</surname><given-names>V.</given-names></name>; <name><surname>Janreddy</surname><given-names>D.</given-names></name>; <name><surname>Bandi</surname><given-names>V.</given-names></name>; <name><surname>Kuo</surname><given-names>C.-W.</given-names></name>; <name><surname>Yao</surname><given-names>C.-F.</given-names></name>
<article-title>Synthesis of 2,3-Disubstituted Quinazolinone
Derivatives through Copper Catalyzed C-H Amidation Reactions</article-title>. <source>Eur. J. Org. Chem.</source>
<year>2016</year>, <volume>2016</volume>, <fpage>1182</fpage>&#x02013;<lpage>1193</lpage><pub-id pub-id-type="doi">10.1002/ejoc.201501552</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit6f"><label> f</label><name><surname>Sharma</surname><given-names>R.</given-names></name>; <name><surname>Vishwakarma</surname><given-names>R. A.</given-names></name>; <name><surname>Bharate</surname><given-names>S. B.</given-names></name>
<article-title>Bimetallic Cu-Mn-Catalyzed Synthesis of 2-Arylquinazolin-4(3H)-ones:
Aqueous Ammonia as Source of a Ring Nitrogen Atom</article-title>. <source>Eur. J. Org. Chem.</source>
<year>2016</year>, <volume>2016</volume>, <fpage>5227</fpage>&#x02013;<lpage>5233</lpage><pub-id pub-id-type="doi">10.1002/ejoc.201601024</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit6g"><label> g</label><name><surname>Upadhyaya</surname><given-names>K.</given-names></name>; <name><surname>Thakur</surname><given-names>R. K.</given-names></name>; <name><surname>Shukla</surname><given-names>S. K.</given-names></name>; <name><surname>Tripathi</surname><given-names>R. P.</given-names></name>
<article-title>One-Pot Copper(I)-Catalyzed Ligand/Base-Free Tandem
Cyclooxidative Synthesis of Quinazolinones</article-title>. <source>J. Org. Chem.</source>
<year>2016</year>, <volume>81</volume>, <fpage>5046</fpage>&#x02013;<lpage>5055</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.6b00599</pub-id>.<pub-id pub-id-type="pmid">27223462</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit6h"><label> h</label><name><surname>Shinde</surname><given-names>M. H.</given-names></name>; <name><surname>Kshirsagar</surname><given-names>U. A.</given-names></name>
<article-title>A copper catalyzed multicomponent
cascade redox reaction for the synthesis of quinazolinones</article-title>. <source>RSC Adv.</source>
<year>2016</year>, <volume>6</volume>, <fpage>52884</fpage>&#x02013;<lpage>52887</lpage><pub-id pub-id-type="doi">10.1039/c6ra10997g</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit6i"><label> i</label><name><surname>Yu</surname><given-names>X.</given-names></name>; <name><surname>Gao</surname><given-names>L.</given-names></name>; <name><surname>Jia</surname><given-names>L.</given-names></name>; <name><surname>Yamamoto</surname><given-names>Y.</given-names></name>; <name><surname>Bao</surname><given-names>M.</given-names></name>
<article-title>Synthesis of quinazolin-4(3<italic>H</italic>)-ones <italic>via</italic> the reaction of 2-halobenzamides with nitriles</article-title>. <source>J. Org. Chem.</source>
<year>2018</year>, <volume>83</volume>, <fpage>10352</fpage>&#x02013;<lpage>10358</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.8b01460</pub-id>.<pub-id pub-id-type="pmid">30084636</pub-id></mixed-citation></ref><ref id="ref7"><note><p>Selected reports, see:</p></note><mixed-citation publication-type="journal" id="cit7a"><label>a</label><name><surname>Cano</surname><given-names>R.</given-names></name>; <name><surname>Ram&#x000f3;n</surname><given-names>D. J.</given-names></name>; <name><surname>Yus</surname><given-names>M.</given-names></name>
<article-title>Transition-Metal-FreeO-,S-,
andN-Arylation
of Alcohols, Thiols, Amides, Amines, and Related Heterocycles</article-title>. <source>J. Org. Chem.</source>
<year>2011</year>, <volume>76</volume>, <fpage>654</fpage>&#x02013;<lpage>660</lpage><pub-id pub-id-type="doi">10.1021/jo1022052</pub-id>.<pub-id pub-id-type="pmid">21175155</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit7b"><label> b</label><name><surname>Beyer</surname><given-names>A.</given-names></name>; <name><surname>Reucher</surname><given-names>C. M. M.</given-names></name>; <name><surname>Bolm</surname><given-names>C.</given-names></name>
<article-title>Potassium hydroxide/dimethyl
sulfoxide promoted intramolecular cyclization for the synthesis of
benzimidazol-2-ones</article-title>. <source>Org. Lett.</source>
<year>2011</year>, <volume>13</volume>, <fpage>2876</fpage>&#x02013;<lpage>2879</lpage><pub-id pub-id-type="doi">10.1021/ol2008878</pub-id>.<pub-id pub-id-type="pmid">21534616</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit7c"><label> c</label><name><surname>Mehta</surname><given-names>V. P.</given-names></name>; <name><surname>Punji</surname><given-names>B.</given-names></name>
<article-title>Recent advances in transition-metal-free direct C-C and C-heteroatom
bond forming reactions</article-title>. <source>RSC Adv.</source>
<year>2013</year>, <volume>3</volume>, <fpage>11957</fpage>&#x02013;<lpage>11986</lpage><pub-id pub-id-type="doi">10.1039/c3ra40813b</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit7d"><label> d</label><name><surname>Baars</surname><given-names>H.</given-names></name>; <name><surname>Beyer</surname><given-names>A.</given-names></name>; <name><surname>Kohlhepp</surname><given-names>S. V.</given-names></name>; <name><surname>Bolm</surname><given-names>C.</given-names></name>
<article-title>Transition-metal-free
synthesis of benzimidazoles mediated by KOH/DMSO</article-title>. <source>Org. Lett.</source>
<year>2014</year>, <volume>16</volume>, <fpage>536</fpage>&#x02013;<lpage>539</lpage><pub-id pub-id-type="doi">10.1021/ol403414v</pub-id>.<pub-id pub-id-type="pmid">24364511</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit7e"><label> e</label><name><surname>Tiwari</surname><given-names>A. R.</given-names></name>; <name><surname>Bhanage</surname><given-names>B. M.</given-names></name>
<article-title>Transition-metal free synthesis of
quinazolinones <italic>via</italic> tandem cyclization of 2-halobenzoic
acids with amidines</article-title>. <source>RSC Adv.</source>
<year>2015</year>, <volume>5</volume>, <fpage>57235</fpage>&#x02013;<lpage>57239</lpage><pub-id pub-id-type="doi">10.1039/c5ra11159e</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit7f"><label> f</label><name><surname>Tsujii</surname><given-names>M.</given-names></name>; <name><surname>Sonoda</surname><given-names>M.</given-names></name>; <name><surname>Tanimori</surname><given-names>S.</given-names></name>
<article-title>Proline-mediated transition metal-free
access to 1<italic>H</italic>-indazolones from 2-halobenzohydrazides</article-title>. <source>J. Org. Chem.</source>
<year>2016</year>, <volume>81</volume>, <fpage>6766</fpage>&#x02013;<lpage>6773</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.6b00651</pub-id>.<pub-id pub-id-type="pmid">27388021</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit7g"><label> g</label><name><surname>Su</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>Q.</given-names></name>; <name><surname>Lu</surname><given-names>L.</given-names></name>; <name><surname>Ma</surname><given-names>Y.</given-names></name>; <name><surname>Auyoung</surname><given-names>G. H. L.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>Base-promoted nucleophilic
fluoroarenes substitution of C F bonds</article-title>. <source>Tetrahedron</source>
<year>2018</year>, <volume>74</volume>, <fpage>303</fpage>&#x02013;<lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2017.11.067</pub-id>.</mixed-citation></ref><ref id="ref8"><note><p>Selected recent reports,
see:</p></note><mixed-citation publication-type="journal" id="cit8a"><label>a</label><name><surname>Zheng</surname><given-names>L.</given-names></name>; <name><surname>Ju</surname><given-names>J.</given-names></name>; <name><surname>Bin</surname><given-names>Y.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>Synthesis
of isoquinolines and heterocycle-fused
pyridines <italic>via</italic> three-component cascade reaction of
aryl ketones, hydroxylamine, and alkynes</article-title>. <source>J.
Org. Chem.</source>
<year>2012</year>, <volume>77</volume>, <fpage>5794</fpage>&#x02013;<lpage>5800</lpage><pub-id pub-id-type="doi">10.1021/jo3010414</pub-id>.<pub-id pub-id-type="pmid">22702218</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit8b"><label> b</label><name><surname>Ju</surname><given-names>J.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>; <name><surname>Su</surname><given-names>J.</given-names></name>
<article-title>Copper-catalyzed three-component
one-pot synthesis of quinazolines</article-title>. <source>Tetrahedron</source>
<year>2012</year>, <volume>68</volume>, <fpage>9364</fpage>&#x02013;<lpage>9370</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2012.09.035</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit8c"><label> c</label><name><surname>Yang</surname><given-names>L.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>Cycloaddition of 1,4-diaryl-1,3-butadiynes
with nitriles: An atom-economic one-pot approach to benzo[<italic>f</italic>]quinazolines</article-title>. <source>Chem. Lett.</source>
<year>2013</year>, <volume>42</volume>, <fpage>769</fpage>&#x02013;<lpage>771</lpage><pub-id pub-id-type="doi">10.1246/cl.130206</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit8d"><label> d</label><name><surname>Ju</surname><given-names>J.</given-names></name>; <name><surname>Qi</surname><given-names>C.</given-names></name>; <name><surname>Zheng</surname><given-names>L.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>Synthesis of 3-methyleneisoindolin-1-ones
via palladium-catalyzed C-Cl bond cleavage and cyclocarbonylation
of ortho-chloro ketimines</article-title>. <source>Tetrahedron Lett.</source>
<year>2013</year>, <volume>54</volume>, <fpage>5159</fpage>&#x02013;<lpage>5161</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2013.07.017</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit8e"><label> e</label><name><surname>Zheng</surname><given-names>L.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>Rhodium (III)-catalyzed C-H activation
and indole synthesis with hydrazone as an auto-formed and auto-cleavable
directing group</article-title>. <source>Chem.&#x02014;Eur. J.</source>
<year>2014</year>, <volume>20</volume>, <fpage>2352</fpage>&#x02013;<lpage>2356</lpage><pub-id pub-id-type="doi">10.1002/chem.201304302</pub-id>.<pub-id pub-id-type="pmid">24458554</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit8f"><label> f</label><name><surname>Zheng</surname><given-names>L.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>Modular Assembly of Ring-Fused and &#x003c0;-Extended Phenanthroimidazoles
via C-H Activation and Alkyne Annulation</article-title>. <source>J.
Org. Chem.</source>
<year>2014</year>, <volume>79</volume>, <fpage>3930</fpage>&#x02013;<lpage>3936</lpage><pub-id pub-id-type="doi">10.1021/jo500401n</pub-id>.<pub-id pub-id-type="pmid">24712329</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit8g"><label> g</label><name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Zheng</surname><given-names>L.</given-names></name>; <name><surname>Guo</surname><given-names>B.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>One-Pot Synthesis
of Multisubstituted 2-Aminoquinolines from Annulation of 1-Aryl Tetrazoles
with Internal Alkynes via Double C-H Activation and Denitrogenation</article-title>. <source>J. Org. Chem.</source>
<year>2014</year>, <volume>79</volume>, <fpage>11541</fpage>&#x02013;<lpage>11548</lpage><pub-id pub-id-type="doi">10.1021/jo502192b</pub-id>.<pub-id pub-id-type="pmid">25389557</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit8h"><label> h</label><name><surname>Zheng</surname><given-names>Q.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>; <name><surname>Jiang</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>
<article-title>A general approach to arylated furans, pyrroles, and thiophenes</article-title>. <source>Tetrahedron</source>
<year>2014</year>, <volume>70</volume>, <fpage>8252</fpage>&#x02013;<lpage>8256</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2014.09.025</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit8i"><label> i</label><name><surname>Su</surname><given-names>J.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>Au(I)-Catalyzed Annulation
of Propargyl Amine with Aldehydes: One-Pot Cascade Synthesis of 2,5-Dimethylpyrazines</article-title>. <source>Int. J. Mol. Sci.</source>
<year>2015</year>, <volume>16</volume>, <fpage>3599</fpage>&#x02013;<lpage>3608</lpage><pub-id pub-id-type="doi">10.3390/ijms16023599</pub-id>.<pub-id pub-id-type="pmid">25664863</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit8j"><label> j</label><name><surname>Zheng</surname><given-names>L.</given-names></name>; <name><surname>Bin</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>Synthesis of Natural Product-like Polyheterocycles via One-Pot Cascade
Oximation, C-H Activation, and Alkyne Annulation</article-title>. <source>J. Org. Chem.</source>
<year>2016</year>, <volume>81</volume>, <fpage>8911</fpage>&#x02013;<lpage>8919</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.6b01460</pub-id>.<pub-id pub-id-type="pmid">27626812</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit8k"><label> k</label><name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Zheng</surname><given-names>L.</given-names></name>; <name><surname>Guo</surname><given-names>B.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>Synthesis of fused polycyclic indoles <italic>via</italic> Cu(II)-catalyzed
intramolecular cyclization of <italic>N</italic>-(2-cyanophenyl)indoles
in the presence of diaryliodonium salts</article-title>. <source>Tetrahedron</source>
<year>2017</year>, <volume>73</volume>, <fpage>395</fpage>&#x02013;<lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2016.12.022</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit8l"><label> l</label><name><surname>Nizami</surname><given-names>T. A.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>Silver-catalyzed chemoselective annulation
of propargyl amines with alkynes for access to pyridines and pyrroles</article-title>. <source>Tetrahedron</source>
<year>2017</year>, <volume>73</volume>, <fpage>6080</fpage>&#x02013;<lpage>6084</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2017.09.002</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit8m"><label> m</label><name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Lu</surname><given-names>L.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>[Cu( malo NHC)]-catalyzed
synthesis of 2-aryl pyrazolo[5,1- a ]isoquinolines by annulation of
N &#x02032;-(2-((trimethylsilyl)ethynyl)benzylidene)hydrazides with
terminal aromatic alkynes</article-title>. <source>Tetrahedron</source>
<year>2017</year>, <volume>73</volume>, <fpage>6428</fpage>&#x02013;<lpage>6435</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2017.09.037</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit8n"><label> n</label><name><surname>Zheng</surname><given-names>L.</given-names></name>; <name><surname>Hua</surname><given-names>R.</given-names></name>
<article-title>C-H Activation and Alkyne Annulation
via Automatic or Intrinsic Directing Groups: Towards High Step Economy</article-title>. <source>Chem. Rec.</source>
<year>2018</year>, <volume>18</volume>, <fpage>556</fpage>&#x02013;<lpage>569</lpage><pub-id pub-id-type="doi">10.1002/tcr.201700024</pub-id>.<pub-id pub-id-type="pmid">28681990</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Beyer</surname><given-names>A.</given-names></name>; <name><surname>Reucher</surname><given-names>C. M. M.</given-names></name>; <name><surname>Bolm</surname><given-names>C.</given-names></name>
<article-title>Potassium
hydroxide/dimethyl sulfoxide
promoted intramolecular cyclization for the synthesis of benzimidazol-2-ones</article-title>. <source>Org. Lett.</source>
<year>2011</year>, <volume>13</volume>, <fpage>2876</fpage>&#x02013;<lpage>2879</lpage><pub-id pub-id-type="doi">10.1021/ol2008878</pub-id>.<pub-id pub-id-type="pmid">21534616</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><comment>An aerobic treatment
of <italic>N</italic>-benzyl amidoximes with Cs<sub>2</sub>CO<sub>3</sub> in DMSO resulting in oxidative skeletal rearrangement to
give quinazolinones as a major product, see:</comment><name><surname>Zhang</surname><given-names>F.-L.</given-names></name>; <name><surname>Wang</surname><given-names>Y.-F.</given-names></name>; <name><surname>Chiba</surname><given-names>S.</given-names></name>
<article-title>Orthogonal aerobic
conversion of <italic>N</italic>-benzyl amidoximes to 1,2,4-oxadiazoles
or quinazolinones</article-title>. <source>Org. Biomol. Chem.</source>
<year>2013</year>, <volume>11</volume>, <fpage>6003</fpage>&#x02013;<lpage>6007</lpage><pub-id pub-id-type="doi">10.1039/c3ob41393d</pub-id>.<pub-id pub-id-type="pmid">23939248</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>M.</given-names></name>; <name><surname>Ding</surname><given-names>M.-W.</given-names></name>
<article-title>Reversible P(III)/P(V)
Redox: Catalytic Aza-Wittig Reaction for the Synthesis of 4(3H)-Quinazolinones
and the Natural Product Vasicinone</article-title>. <source>Adv. Synth.
Catal.</source>
<year>2014</year>, <volume>356</volume>, <fpage>1098</fpage>&#x02013;<lpage>1104</lpage><pub-id pub-id-type="doi">10.1002/adsc.201300950</pub-id>.</mixed-citation></ref></ref-list></back></article>